These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8546422)

  • 81. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia in a large cohort.
    Dharia I; Bielamowicz S
    Laryngoscope; 2020 Nov; 130(11):2659-2662. PubMed ID: 31837152
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
    Maronian NC; Waugh PF; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues.
    Young DL; Halstead LA
    J Voice; 2014 Sep; 28(5):614-7. PubMed ID: 24954039
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficacy of repeated botulinum toxin injections as a function of timing.
    Inagi K; Ford CN; Rodriquez AA; Schultz E; Bless DM; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1012-9. PubMed ID: 9415596
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The point-touch technique for botulinum toxin injection in adductor spasmodic dysphonia: quality of life assessment.
    Morzaria S; Damrose EJ
    J Laryngol Otol; 2011 Jul; 125(7):714-8. PubMed ID: 21524329
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Stridor and focal laryngeal dystonia.
    Marion MH; Klap P; Perrin A; Cohen M
    Lancet; 1992 Feb; 339(8791):457-8. PubMed ID: 1346820
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of ventricular dysphonia with botulinum toxin.
    Kendall KA; Leonard RJ
    Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.
    Kaderbay A; Righini CA; Castellanos PF; Atallah I
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Jun; 135(3):205-207. PubMed ID: 29661610
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bilateral thyroarytenoid denervation: a new treatment for laryngeal hyperadduction disorders studied in the canine.
    Sercarz JA; Berke GS; Ming Y; Rothschiller J; Graves MC
    Otolaryngol Head Neck Surg; 1992 Nov; 107(5):657-68. PubMed ID: 1437204
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Treatment of spasticity with botulinum toxin].
    Mémin B; Pollak P; Hommel M; Perret J
    Rev Neurol (Paris); 1992; 148(3):212-4. PubMed ID: 1604136
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Contemporary management of spasmodic dysphonia.
    Sulica L
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):543-8. PubMed ID: 15548915
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Teaching video NeuroImage: Spasmodic dysphonia: adductor and abductor.
    Reich SG; Meyer T
    Neurology; 2008 May; 70(19):e78. PubMed ID: 18458222
    [No Abstract]   [Full Text] [Related]  

  • 94. Long-term follow-up of recurrent laryngeal nerve avulsion for the treatment of spastic dysphonia.
    Weed DT; Jewett BS; Rainey C; Zealear DL; Stone RE; Ossoff RH; Netterville JL
    Ann Otol Rhinol Laryngol; 1996 Aug; 105(8):592-601. PubMed ID: 8712628
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia.
    Galardi G; Guerriero R; Amadio S; Leocani L; Teggi R; Melloni G; Comi G
    Neurol Sci; 2001 Aug; 22(4):303-6. PubMed ID: 11808853
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Alternating unilateral botulinum toxin type A (BOTOX) injections for spasmodic dysphonia.
    Koriwchak MJ; Netterville JL; Snowden T; Courey M; Ossoff RH
    Laryngoscope; 1996 Dec; 106(12 Pt 1):1476-81. PubMed ID: 8948606
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Botulinum toxin injection for abductor spasmodic dysphonia under cervical ultrasonography guidance.
    Kunieda C; Nin F; Ohashi T; Hosokawa K; Watanabe Y; Ogawa T; Mori T; Kanazawa T
    Auris Nasus Larynx; 2024 Apr; 51(2):361-364. PubMed ID: 37838568
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.
    Whurr R; Nye C; Lorch M
    Int J Lang Commun Disord; 1998; 33 Suppl():327-9. PubMed ID: 10343714
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Laryngeal Botulinum Toxin Injection: Can It Be a Cause of Obstructive Sleep Apnea as an Adverse Effect?
    Oktay Arslan B; Demirhan E; Uçar Hoşgör ZZ
    J Voice; 2022 Jan; 36(1):119-122. PubMed ID: 32482493
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.
    Mehta RP; Goldman SN; Orloff LA
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):393-9. PubMed ID: 11296047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.